NL7013663A - - Google Patents

Info

Publication number
NL7013663A
NL7013663A NL7013663A NL7013663A NL7013663A NL 7013663 A NL7013663 A NL 7013663A NL 7013663 A NL7013663 A NL 7013663A NL 7013663 A NL7013663 A NL 7013663A NL 7013663 A NL7013663 A NL 7013663A
Authority
NL
Netherlands
Application number
NL7013663A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7013663A publication Critical patent/NL7013663A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7013663A 1969-09-17 1970-09-16 NL7013663A (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85924469A 1969-09-17 1969-09-17

Publications (1)

Publication Number Publication Date
NL7013663A true NL7013663A (https=) 1971-03-19

Family

ID=25330421

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7013663A NL7013663A (https=) 1969-09-17 1970-09-16

Country Status (13)

Country Link
US (1) US3649691A (https=)
JP (1) JPS494218B1 (https=)
BE (1) BE755071A (https=)
BR (1) BR7022215D0 (https=)
CH (1) CH540882A (https=)
DE (1) DE2046043C3 (https=)
DK (1) DK139356B (https=)
ES (1) ES383643A1 (https=)
FR (1) FR2068537B1 (https=)
GB (1) GB1264775A (https=)
NL (1) NL7013663A (https=)
NO (1) NO135141C (https=)
ZA (1) ZA704981B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130393C3 (de) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen
GB1464950A (en) * 1973-05-03 1977-02-16 Squibb & Sons Inc Naphthalene derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
CH621330A5 (https=) * 1976-05-14 1981-01-30 Sandoz Ag
JPS5334024U (https=) * 1976-08-31 1978-03-25
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
US5266599A (en) * 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
EA009646B1 (ru) * 2003-05-30 2008-02-28 Рэнбакси Лабораториз Лтд. Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
BRPI0714361A2 (pt) * 2006-07-14 2013-03-26 Ranbaxy Lab Ltd polimorfo cristalino, composiÇço farmacÊutica contendo o mesmo, mÉtodo para sua preparaÇço e mÉtodo de tratamento
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2974148A (en) * 1959-03-30 1961-03-07 Smith Kline French Lab Anorexigenic preparation and method of curbing the appetite
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines

Also Published As

Publication number Publication date
ZA704981B (en) 1971-07-28
DK139356B (da) 1979-02-05
DE2046043C3 (de) 1978-12-14
CH540882A (de) 1973-08-31
DK139356C (https=) 1979-08-20
BE755071A (fr) 1971-02-22
DE2046043A1 (de) 1971-03-25
NO135141B (https=) 1976-11-08
FR2068537A1 (https=) 1971-08-27
FR2068537B1 (https=) 1974-02-01
JPS494218B1 (https=) 1974-01-31
NO135141C (https=) 1977-02-16
ES383643A1 (es) 1976-06-01
BR7022215D0 (pt) 1973-04-26
GB1264775A (https=) 1972-02-23
US3649691A (en) 1972-03-14
DE2046043B2 (de) 1978-03-30

Similar Documents

Publication Publication Date Title
AU465452B2 (https=)
AU429630B2 (https=)
FR2068537B1 (https=)
AU450150B2 (https=)
AU442375B2 (https=)
AU2355770A (https=)
AU470301B1 (https=)
AU5113869A (https=)
AU442554B2 (https=)
AU428129B2 (https=)
AU470661B1 (https=)
AU438128B2 (https=)
AU410358B2 (https=)
AU442285B2 (https=)
AU442322B2 (https=)
AU442357B2 (https=)
AU428074B2 (https=)
AU442463B2 (https=)
AU442535B2 (https=)
AU442538B2 (https=)
AU425297B2 (https=)
AU414607B2 (https=)
AU417208B2 (https=)
AU5228269A (https=)
AU5598769A (https=)